Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in EUR
The 4 analysts offering 12 month price targets for Dermapharm Holding SE have a median target of 49.50, with a high estimate of 58.00 and a low estimate of 41.50. The median estimate represents a 42.24% increase from the last price of 34.80.
High | 66.7% | 58.00 |
Med | 42.2% | 49.50 |
Low | 19.3% | 41.50 |
Dividends
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in EUR
The next earnings announcement is expected on Mar 31, 2025.
Average growth rate | -8.75% |
Average growth rate | +16.61% |
More ▼
Revenue history & estimates in EUR
Average growth rate | -1.27% |
Average growth rate | +12.88% |
More ▼